aktiia
The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.
Aktiia announced an oversubscribed $42 million Series B round, and Basil Systems secured $11.5 million in funding.